South Korea · Delayed Price · Currency is KRW Aprogen Medicines Statistics
Total Valuation
KRX:007460 has a market cap or net worth of KRW 45.09 billion. The enterprise value is 537.07 billion.
| Market Cap | 45.09B |
| Enterprise Value | 537.07B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:007460 has 22.21 million shares outstanding. The number of shares has increased by 10.95% in one year.
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +10.95% |
| Shares Change (QoQ) | +5.02% |
| Owned by Insiders (%) | 6.42% |
| Owned by Institutions (%) | 0.05% |
| Float | 13.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 0.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.44.
| Current Ratio | 0.83 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.72 |
| Interest Coverage | -12.23 |
Financial Efficiency
Return on equity (ROE) is -30.36% and return on invested capital (ROIC) is -14.23%.
| Return on Equity (ROE) | -30.36% |
| Return on Assets (ROA) | -6.78% |
| Return on Invested Capital (ROIC) | -14.23% |
| Return on Capital Employed (ROCE) | -16.76% |
| Weighted Average Cost of Capital (WACC) | 3.24% |
| Revenue Per Employee | 549.01M |
| Profits Per Employee | -330.16M |
| Employee Count | 253 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, KRX:007460 has paid 1.36 billion in taxes.
| Income Tax | 1.36B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.79% in the last 52 weeks. The beta is 0.10, so KRX:007460's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -81.79% |
| 50-Day Moving Average | 2,332.50 |
| 200-Day Moving Average | 6,120.43 |
| Relative Strength Index (RSI) | 38.29 |
| Average Volume (20 Days) | 673,653 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:007460 had revenue of KRW 138.90 billion and -83.53 billion in losses. Loss per share was -4,035.31.
| Revenue | 138.90B |
| Gross Profit | 34.59B |
| Operating Income | -80.39B |
| Pretax Income | -137.28B |
| Net Income | -83.53B |
| EBITDA | -57.12B |
| EBIT | -80.39B |
| Loss Per Share | -4,035.31 |
Balance Sheet
The company has 43.16 billion in cash and 181.45 billion in debt, with a net cash position of -138.28 billion or -6,225.84 per share.
| Cash & Cash Equivalents | 43.16B |
| Total Debt | 181.45B |
| Net Cash | -138.28B |
| Net Cash Per Share | -6,225.84 |
| Equity (Book Value) | 414.25B |
| Book Value Per Share | 2,803.16 |
| Working Capital | -32.23B |
Cash Flow
In the last 12 months, operating cash flow was -62.79 billion and capital expenditures -3.99 billion, giving a free cash flow of -66.78 billion.
| Operating Cash Flow | -62.79B |
| Capital Expenditures | -3.99B |
| Depreciation & Amortization | 23.26B |
| Net Borrowing | -27.84B |
| Free Cash Flow | -66.78B |
| FCF Per Share | -3,006.67 |
Margins
Gross margin is 24.90%, with operating and profit margins of -57.87% and -60.14%.
| Gross Margin | 24.90% |
| Operating Margin | -57.87% |
| Pretax Margin | -98.83% |
| Profit Margin | -60.14% |
| EBITDA Margin | -41.13% |
| EBIT Margin | -57.87% |
| FCF Margin | n/a |
Dividends & Yields
KRX:007460 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.95% |
| Shareholder Yield | -10.95% |
| Earnings Yield | -185.26% |
| FCF Yield | -148.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2026. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Apr 14, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
KRX:007460 has an Altman Z-Score of -0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.61 |
| Piotroski F-Score | 3 |